Press Releases - 2014

RSS
Where You Are:

Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets

TAMPA, Fla. (Nov. 19, 2014) – Mutations in genes that are never observed may be potential therapeutic targets

 

Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases

TAMPA, Fla. (Nov. 17, 2014) – Licensing and research collaboration deal with Celgene is one of the most significant in Moffitt history

 

Moffitt Cancer Center Researchers Discover Common Chemotherapeutic Agent Reduces Resistance to Virus Therapy in Brain Tumor Patients

TAMPA, Fla. (Nov. 11, 2014) – Cyclophosphamide reduces immune cell influx after oncolytic virus infection and improves therapy success

 

Moffitt Cancer Center Applauds Medicare Coverage Decision on Lung Cancer Screening

TAMPA, Fla. (Nov. 11, 2014) — Draft decision means responsible screening already taking place at Moffitt would be covered

 

Moffitt Cancer Center, M2Gen Tapped To Coordinate Central Laboratory and Biorepository Services for Myelodysplastic Syndromes

TAMPA, Fla. (Nov. 4, 2014) – The joint venture with the National Heart, Lung and Blood Institute will support the National MDS Natural History Study

 

Synthetic Lethality Offers a New Approach to Kill Tumor Cells, Explains Moffitt Cancer Center Researcher

TAMPA, Fla. (Oct. 30, 2014) – Synthetic Lethality maximizes drug effects on cancer cells by taking advantage of cellular alterations

 

Moffitt Faculty Member Receives Prestigious Paul Calabresi Award

TAMPA, Fla. (Oct. 28, 2014) – Martine Extermann, M.D., Ph.D., honored at the International Society of Geriatric Oncology’s Annual Meeting in Portugal

 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions